Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2010 (2010), Article ID 627401, 5 pages
http://dx.doi.org/10.1155/2010/627401
Review Article

Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type

Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong

Received 4 August 2010; Accepted 20 December 2010

Academic Editor: Jorge Enrique Romaguera

Copyright © 2010 Harinder Gill et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Spits, L. L. Lanier, and J. H. Phillips, “Development of human T and natural killer cells,” Blood, vol. 85, no. 10, pp. 2654–2670, 1995. View at Google Scholar · View at Scopus
  2. J. K. C. Chan, L. Quintanilla-Martinez, J. A. Ferry, and S. C. Peh, “Extranodal NK/T—cell lymphoma, nasal type,” in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, pp. 285–288, International Agency for Research on Cancer, Lyon, France, 2008. View at Google Scholar
  3. J. K. C. Chan, E. S. Jaffe, E. Ralfkiaer, and Y. H. Ko, “Aggressive NK—cell leukaemia,” in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, pp. 276–277, International Agency for Research on Cancer, Lyon, France, 2008. View at Google Scholar
  4. L. J. Medeiros, S. C. Peiper, L. Elwood, T. Yano, M. Raffeld, and E. S. Jaffe, “Angiocentric immunoproliferative lesions: a molecular analysis of eight cases,” Human Pathology, vol. 22, no. 11, pp. 1150–1157, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. F. C. S. Ho, G. Srivastava, S. L. Loke et al., “Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type,” Hematological Oncology, vol. 8, no. 5, pp. 271–281, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. A. B. Gelb, M. van de Rijn, D. P. Regula Jr. et al., “Eptein—Barr virus—associated natural kieelr—large granular lymphocyte leukaemia,” Human Pathology, vol. 25, pp. 953–960, 1994. View at Google Scholar
  7. L. Quintanilla-Martinez, M. Kremer, G. Keller et al., “p53 mutations in nasal natural killer/T-cell lymphoma from mexico: association with large cell morphology and advanced disease,” American Journal of Pathology, vol. 159, no. 6, pp. 2095–2105, 2001. View at Google Scholar · View at Scopus
  8. W. Y. Au, S. Y. Ma, C. S. Chim et al., “Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years,” Annals of Oncology, vol. 16, no. 2, pp. 206–214, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. O. Armitage, “A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma,” Blood, vol. 89, no. 11, pp. 3909–3918, 1997. View at Google Scholar · View at Scopus
  10. R. P. Hasserjian and N. L. Harris, “NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype,” American Journal of Clinical Pathology, vol. 127, no. 6, pp. 860–868, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. Ando, K. Sugimoto, M. Ando, Y. Isobe, M. Sasaki, and K. Oshimi, “CD20-positive extranodal NK-cell lymphoma, nasal-type,” European Journal of Haematology, vol. 80, no. 6, pp. 549–550, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. H. S. Gill, W.-H. Lau, A. C.L. Chan et al., “CD20 expression in natural killer T cell lymphoma,” Histopathology, vol. 57, no. 1, pp. 147–167, 2010. View at Google Scholar
  13. Y. L. Kwong, “Natural killer-cell malignancies: diagnosis and treatment,” Leukemia, vol. 19, no. 12, pp. 2186–2194, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. R. Liang, “Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type,” British Journal of Haematology, vol. 147, no. 1, pp. 13–21, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. K. T. Robbins, L. M. Fuller, and B. Osborne, “Primary lymphomas of the nasal cavity and paranasal sinuses,” Cancer, vol. 56, no. 4, pp. 814–819, 1985. View at Google Scholar · View at Scopus
  16. G. C. Ooi, C. S. Chim, R. Liang, K. W. T. Tsang, and Y. L. Kwong, “Original report. Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity,” American Journal of Roentgenology, vol. 174, no. 4, pp. 1141–1145, 2000. View at Google Scholar · View at Scopus
  17. P. L. Khong, C. B. Y. Pang, R. Liang, Y. L. Kwong, and W. Y. Au, “Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies,” Annals of Hematology, vol. 87, no. 8, pp. 613–621, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. W. K.S. Chan, W.-Y. Au, C.-Y.O. Wong et al., “Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B-and T-cell lymphomas,” Clinical Nuclear Medicine, vol. 35, no. 8, pp. 571–575, 2010. View at Publisher · View at Google Scholar · View at PubMed
  19. K. C. A. Chan, J. Zhang, A. T. C. Chan et al., “Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients,” Cancer Research, vol. 63, no. 9, pp. 2028–2032, 2003. View at Google Scholar · View at Scopus
  20. W. Y. Au, A. Pang, C. Choy, C. S. Chim, and Y. L. Kwong, “Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients,” Blood, vol. 104, no. 1, pp. 243–249, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. R. Suzuki, J. Suzumiya, M. Yamaguchi et al., “Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type,” Annals of Oncology, vol. 21, no. 5, pp. 1032–1040, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. J. Lee, C. Suh, H. P. Yeon et al., “Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study,” Journal of Clinical Oncology, vol. 24, no. 4, pp. 612–618, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. M. C. Cheung, J. K. C. Chan, W. H. Lau, R. K. C. Ngan, and W. W. L. Foo, “Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality,” International Journal of Radiation Oncology Biology Physics, vol. 54, no. 1, pp. 182–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Y. Au, S. J. Kim, H. H. Y. Yiu et al., “Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission,” American Journal of Hematology, vol. 85, no. 5, pp. 362–363, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. Yamaguchi, K. Kita, H. Miwa et al., “Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells,” Cancer, vol. 76, no. 11, pp. 2351–2356, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Yamaguchi, K. Tobinai, M. Oguchi et al., “Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan clinical oncology group study JCOG0211,” Journal of Clinical Oncology, vol. 27, no. 33, pp. 5594–5600, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. J. Kim, K. Kim, B. S. Kim et al., “Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: consortium for improving survival of lymphoma study,” Journal of Clinical Oncology, vol. 27, no. 35, pp. 6027–6032, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. W. Yong, W. Zheng, J. Zhu et al., “L-asparaginase in the treatment of refractory and relapsed extranodal NK/ T-cell lymphoma, nasal type,” Annals of Hematology, vol. 88, no. 7, pp. 647–652, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. M. Yamaguchi, R. Suzuki, Y. L. Kwong et al., “Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia,” Cancer Science, vol. 99, no. 5, pp. 1016–1020, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. Y. L. Kwong, “High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies,” Bone Marrow Transplantation, vol. 44, no. 11, pp. 709–714, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. Lee, W. Y. Au, M. J. Park et al., “Autologous hematopoietic stem cell transplantation in extranodal natural killer/ T cell lymphoma: a multinational, multicenter, matched controlled study,” Biology of Blood and Marrow Transplantation, vol. 14, no. 12, pp. 1356–1364, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. H. Yokoyama, J. Yamamoto, Y. Tohmiya et al., “Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type,” Leukemia and Lymphoma, vol. 51, no. 8, pp. 1509–1512, 2010. View at Publisher · View at Google Scholar · View at PubMed